Aucentra discovers and develops oral small molecules for a range of cancers. Our pipeline of candidates includes highly potent and selective, first-in-class CDK inhibitors. Established in 2017, we develop breakthrough classes of drugs to address unmet medical need for some of the most severe cancer...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (9 years)
Address:
NORTH TERRACE; ADELAIDE, SOUTH AUSTRALIA 5000, AU
LOW
spending power